Making Cisplatin Nanoparticles

  • Author: Melania Tesio
  • Published: 03 August 2012
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Proceedings of the National Academy of Sciences/National Academy of Sciences
thumbnail image: Making Cisplatin Nanoparticles

Cisplatin, cis-dichlorodiamineplatinum (II) (pictured), is a chemotherapeutic agent used for many forms of cancer. Its formulation as nanodrugs is however challenging. Poulomi Sengupta, Brigham and Women’s Hospital, Cambridge, USA, used a strategy based on supramolecular chemistry to develop self-assembling cholesterol-succinic acid-cisplatinum II-based nanoparticles (SACNs).

These possess an enhanced antitumor activity compared to free cisplatin. Their increased efficacy is attributable to an efficient release, at the tumor site, of active platinum obtained by introducing the monocarboxylato and O→Pt coordination environment between the platinum and the cholesterol succinic acid conjugate.
This feature together with a reduced nephric and systemic toxicity renders SACNs new promising platinum based drugs.

Article Views: 2836

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH